BLCM Quote, Trading Chart, Bellicum Pharmaceuticals Inc.
home / stock / blcm / blcm quote
$3.69 Last:
-2.12% Change Percent:
$3.66 Open:
$3.69 Previous Close:
$3.8 High:
$3.3102 Low:
429,923 Volume:
03/05/2021 04:55:19 pm Last Trade Date Time:
Quotes are delayed by 15 to 20 minutes.
Last Five Trading Days
| Stock Date | Open Price | Close Price | High | Low | Volume |
|---|---|---|---|---|---|
| 2021-03-05 | 3.66 | 3.69 | 3.8 | 3.3102 | 429,923 |
| 2021-03-04 | 4.03 | 3.77 | 4.45 | 3.5 | 1,191,415 |
| 2021-03-03 | 4.2 | 3.85 | 4.21 | 3.85 | 598,491 |
| 2021-03-02 | 4.4 | 4.17 | 4.56 | 3.88 | 443,495 |
| 2021-03-01 | 4.45 | 4.41 | 4.61 | 4.28 | 256,684 |
| 2021-02-26 | 4.56 | 4.37 | 4.69 | 4.22 | 477,908 |
| 2021-02-25 | 4.93 | 4.47 | 5.13 | 4.37 | 256,318 |
| 2021-02-24 | 4.65 | 4.86 | 5.19 | 4.58 | 369,152 |
| 2021-02-23 | 4.73 | 4.62 | 4.8 | 4.2 | 455,709 |
| 2021-02-22 | 5.57 | 4.96 | 5.65 | 4.94 | 756,500 |
| 2021-02-19 | 5.99 | 5.67 | 6.09 | 5.51 | 667,768 |
| 2021-02-18 | 6.39 | 6.05 | 6.8 | 5.96 | 729,763 |
| 2021-02-17 | 6.8535 | 6.58 | 6.86 | 6.28 | 773,740 |
| 2021-02-16 | 7 | 7.02 | 7.44 | 6.8 | 939,111 |
| 2021-02-15 | 5.57 | 6.64 | 6.73 | 5.3001 | 1,661,727 |
| 2021-02-12 | 5.57 | 6.64 | 6.73 | 5.3001 | 1,471,159 |
| 2021-02-11 | 5.929 | 5.94 | 8.15 | 5.5 | 6,908,110 |
| 2021-02-10 | 4.9 | 5.28 | 5.32 | 4.55 | 1,315,802 |
| 2021-02-09 | 4.8 | 4.97 | 5.13 | 4.77 | 666,646 |
| 2021-02-08 | 4.59 | 4.76 | 4.9 | 4.478 | 572,559 |
Bellicum Pharmaceuticals Inc. Company Name:
BLCM Stock Symbol:
NASDAQ Market:
Bellicum Pharmaceuticals Inc. Website:
News, Short Squeeze, Breakout and More Instantly...
-
HOUSTON, March 04, 2021 (GLOBE NEWSWIRE) -- Bellicum Pharmaceuticals, Inc. (NASDAQ:BLCM), a leader in developing novel, controllable cellular immunotherapies for cancers, today announced the publication of a case report using the company’s CaspaCIDe (inducible caspase-9, or iC9) safe...
-
Ponce Therapeutics Inc. Commences First R & D Program in Anti-Aging Products for Skin Ponce Therapeutics Inc. Commences First R & D Program in Anti-Aging Products for Skin Rapha Capital Management Leads Convertible Note Financing PR Newswire MIAMI , ...
-
Will These Biotech Penny Stocks Continue to Make Moves Next Month? With February right around the corner, we see heightened momentum in the stock market. After the Gamestop Corp. ( NYSE: GME ) debacle on Wednesday, January 27th, traders are figuring out how to find the best pe...